Bazemore Robert B
President & CEO at Epizyme, Inc.
- Sold, on record
- $984k
- Dollars the filings state
- Form 4 sales
- 8
- Latest Mar 25, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Epizyme, Inc.President & CEO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Epizyme, Inc.Plan not statedJun 13 2019
Sold 2,074 shares at $12.10 ($25k)
Bazemore Robert B, President & CEO
Sold 2.4% of holdings ($1.1M position)84,994 shares leftFirst sale on recordFiling
- 2 Form 4 sale Epizyme, Inc.Plan not statedJan 27 +228 days
Sold 9,076 shares at $21.82 ($198k)
Bazemore Robert B, President & CEO
Sold 9.7% of holdings ($2M position)84,668 shares leftFiling
- 3 Form 4 sale Epizyme, Inc.Plan not statedMar 25 +58 days
Sold 3,285 shares at $15.28 ($50k)
Bazemore Robert B, President & CEO
Sold 1.3% of holdings ($3.9M position)254,371 shares leftFiling
- 4 Form 4 sale Epizyme, Inc.UnusualJun 18 +85 days
Sold 20,000 shares at $22.00 ($440k)
Bazemore Robert B, President & CEO
Sold 7.6% of holdings ($5.8M position)244,371 shares left6.1x usual sizeFiling
- 5 Form 4 sale Epizyme, Inc.Plan not statedJun 26 +8 days
Sold 4,773 shares at $16.15 ($77k)
Bazemore Robert B, President & CEO
Sold 1.9% of holdings ($4.1M position)250,098 shares left0.8x usual sizeFiling
- 6 Form 4 sale Epizyme, Inc.Plan not statedJan 25 +213 days
Sold 6,069 shares at $11.41 ($69k)
Bazemore Robert B, President & CEO
Sold 2.4% of holdings ($2.9M position)248,367 shares left1.3x usual sizeFiling
- 7 Form 4 sale Epizyme, Inc.Plan not statedFeb 4 +10 days
Sold 3,890 shares at $11.21 ($44k)
Bazemore Robert B, President & CEO
Sold 1.2% of holdings ($3.8M position)331,977 shares left0.7x usual sizeFiling
- 8 Form 4 sale Epizyme, Inc.Plan not statedMar 25 +49 days
Sold 10,328 shares at $7.85 ($81k)
Bazemore Robert B, President & CEO
Sold 3.1% of holdings ($2.6M position)322,626 shares left2.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2021 | Epizyme, Inc. | President & CEO | Form 4 sale | 10,328 | $81k | 3.1% | Plan not stated | SEC |
| Feb 4, 2021 | Epizyme, Inc. | President & CEO | Form 4 sale | 3,890 | $44k | 1.2% | Plan not stated | SEC |
| Jan 25, 2021 | Epizyme, Inc. | President & CEO | Form 4 sale | 6,069 | $69k | 2.4% | Plan not stated | SEC |
| Jun 26, 2020 | Epizyme, Inc. | President & CEO | Form 4 sale | 4,773 | $77k | 1.9% | Plan not stated | SEC |
| Jun 18, 2020 | Epizyme, Inc. | President & CEO | Form 4 sale | 20,000 | $440k | 7.6% | Unusual | SEC |
| Mar 25, 2020 | Epizyme, Inc. | President & CEO | Form 4 sale | 3,285 | $50k | 1.3% | Plan not stated | SEC |
| Jan 27, 2020 | Epizyme, Inc. | President & CEO | Form 4 sale | 9,076 | $198k | 9.7% | Plan not stated | SEC |
| Jun 13, 2019 | Epizyme, Inc. | President & CEO | Form 4 sale | 2,074 | $25k | 2.4% | Plan not stated | SEC |